Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ImmVira's Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma Obtained FDA's Orphan Drug Designation 2022-08-08 08:30
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy 2022-08-07 07:00
WeTrade Group Announced a Strategic Partnership with Jiqing Bio Company, to Exclusively Sell Monkeypox Test Kits and Antigen Tests 2022-08-05 21:10
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms 2022-08-05 20:45
Yiling's Lianhua Health Products Well-received: CICPE 2022-08-05 15:54
111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow 2022-08-05 14:26
CGBio Signing a North America Out-license Contract on "Novosis rhBMP-2," a Bone Substitute with Orthofix, USA 2022-08-04 21:00
Waterdrop Releases the 2020-21 ESG Report - Striving to Provide High-quality and Sustainable Protection to Billions of Families 2022-08-04 21:00
The Debut of TIANGEN Received Passionate Feedback at AACC 2022 2022-08-04 18:30
RADIOPHARM ENTERS INTO STRATEGIC COLLABORATION WITH LANTHEUS AND ASSUMES PD-L1 LICENSING AGREEMENT FROM NANOMAB 2022-08-04 10:15
ProfoundBio Receives FDA "Study May Proceed" Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer 2022-08-03 20:00
ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022 2022-08-03 20:00
Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US 2022-08-03 19:38
Sanyou Biopharmaceuticals Closed the Series B+ Financing Round of Tens of Millions of RMB Led by Huatai Zijin 2022-08-03 08:00
GenKOre develops hypercompact base editing system 2022-08-02 22:44
Gracell Biotechnologies to Report Second Quarter 2022 Financial on Monday, August 15, 2022 2022-08-02 21:00
CARsgen Appoints Dr. Hua Jiang as Executive Director 2022-08-02 20:50
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies 2022-08-02 20:39
Chime Biologics Received Commercial Manufacturing License Indicating the Kick-off into the Era of Commercial Production 2022-08-02 20:15
China Life Insurance Company Limited - Change of President 2022-08-02 18:57
1 146 147 148 149 150 801